盧寵茂醫生 - 外科
外科專科醫生
重點資料
- 醫務委員會註冊已驗證
- 1 個診所地點薄扶林
- 外科專科醫生香港大學內外全科醫學士 · 英國愛丁堡皇家外科醫學院院士 · 澳洲皇家外科醫學院院士 · 1985 年醫科畢業
- 保險計劃資料整理中｜查看詳情
關於醫生
盧寵茂醫生是薄扶林的外科醫生。
學歷
外科專科醫生
- 香港大學內外全科醫學士1985
- 英國愛丁堡皇家外科醫學院院士1989
- 澳洲皇家外科醫學院院士1992
- 香港醫學專科學院院士(外科)1993
地點
保險計劃
常見問題
盧寵茂醫生好嗎？
盧寵茂醫生是薄扶林的外科醫生。資歷及註冊資料來自香港醫務委員會。ok.med 不評分，也不排名。
盧寵茂醫生是做什麼的？
盧寵茂醫生是外科醫生。
盧寵茂醫生在哪裡看診？
盧寵茂醫生於薄扶林應診。
研究及論文
共 89 篇，顯示最近 12 篇
按論文主題篩選
主題由同一批 PubMed 論文的醫學分類整理，不代表醫生提供相關診治服務。
- Correction: Liver transplantation for acute-on-chronic liver failure.Hepatology international · 2026
- Treatments of transarterial chemoembolization (TACE), stereotactic body radiotherapy (SBRT) and immunotherapy reshape the systemic tumor immune environment (STIE) in patients with unresectable hepatocellular carcinoma.Journal of the National Cancer Center · 2025
- Correction: Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.Annals of surgical oncology · 2025
- Stereotactic Body Radiotherapy and Liver Transplant for Liver Cancer: A Nonrandomized Controlled Trial.JAMA network open · 2024
- Indications of pro-inflammatory cytokines in laparoscopic and open liver resection for early-stage hepatocellular carcinoma.Hepatobiliary & pancreatic diseases international : HBPD INT · 2024
- Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial.The lancet. Gastroenterology & hepatology · 2023
- Isoformic PD-1-mediated immunosuppression underlies resistance to PD-1 blockade in hepatocellular carcinoma patients.Gut · 2023
- A machine learning model for colorectal liver metastasis post-hepatectomy prognostications.Hepatobiliary surgery and nutrition · 2023
- High prevalence of de novo metabolic dysfunction-associated fatty liver disease after liver transplantation and the role of controlled attenuation parameter.BMC gastroenterology · 2023
- Development and validation of an artificial intelligence model for predicting post-transplant hepatocellular cancer recurrence.Cancer communications (London, England) · 2023
- Defining the surgical management for non-colorectal liver metastases.Langenbeck's archives of surgery · 2023
- The role of stereotactic body radiotherapy in hepatocellular carcinoma: guidelines and evidences.Journal of the National Cancer Center · 2022
論文資料來自 PubMed／Europe PMC，按姓名及機構自動配對；每項均可按連結核對。
僅供參考，不構成醫療建議。 閱讀完整免責聲明